Franck Grimaud

Franck Grimaud

Director/Board Member bei IOMAI CORPORATION

Vermögen: 2 Mio $ am 31.03.2024

58 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Franck Charles Marie Grimaud founded Vivalis SA in 1999, where he worked as President, CEO & Head-Investor Relations from 2010 to 2013.
Mr. Grimaud also currently works at Intercell USA, Inc., as Director & Deputy Chief Executive Officer from 2015, Atlantic Biotherapies, as Chief Executive Officer & Director, Valneva USA, Inc., as Director & Deputy Chief Executive Officer from 2015, Pays de la Loire Participations, as Chairman-Governing Board from 2016, Atlanpole Biotherapies, as Chairman from 2018, Fonds Pays De La Loire Participations, as Chairman-Governing Board from 2016, Valneva Scotland Ltd., as Director from 2017, VALNEVA Austria GmbH, as Co-Managing Director from 2013, Vaccines Holdings Sweden AB, as Director & Managing Director from 2014, BliNK Biomedical SAS, as Director, Valneva Sweden AB, as Director from 2015, Valneva UK Ltd., as Director from 2015, Valneva Canada, Inc., as Director & President from 2015, Valneva SE, as Chief Business Officer, and Intercell Austria AG, as Chief Business Officer from 2013.
Mr. Grimaud also formerly worked at Vivalis Toyama Japan KK, as Chairman from 2013 to 2018, France Biotech Association, as Director, Smol Therapeutics SAS, as President & Managing Director, Grimaud Deyang Animal Co. Ltd., as Director from 2000 to 2019, and Chengdu Grimaud Breeding Co. Ltd., as Director from 2000 to 2018.
Mr. Grimaud received his Masters Business Admin degree from the University of Ottawa.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
31.12.2023 635 218 ( 0,46% ) 2 Mio $ 31.03.2024

Aktive Positionen von Franck Grimaud

UnternehmenPositionBeginn
VALNEVA Corporate Officer/Principal -
IOMAI CORPORATION Director/Board Member 01.12.2015
Director/Board Member 01.06.2017
Chairman 01.02.2018
Director/Board Member -
Director/Board Member 01.09.2016
Valneva USA, Inc. Chief Executive Officer 01.12.2015
Intercell Austria AG Corporate Officer/Principal 01.01.2013
President 01.01.2015
░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Alle aktiven Positionen von Franck Grimaud

Ehemalige bekannte Positionen von Franck Grimaud

UnternehmenPositionEnde
░░░░░░░ ░░░░░░ ░░░░░░ ░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Franck Grimaud im Detail an

Ausbildung von Franck Grimaud

University of Ottawa Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Franck Grimaud im Detail an

Beziehungen

54

Beziehungen ersten Grades

21

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen1
VALNEVA

Health Technology

Private Unternehmen19

Health Technology

Health Technology

Commercial Services

Health Technology

Atlantic Biotherapies

Commercial Services

Smol Therapeutics SAS

Vivalis Toyama Japan KK

Grimaud Deyang Animal Co. Ltd.

Chengdu Grimaud Breeding Co. Ltd.

Commercial Services

Health Technology

Health Technology

Health Technology

Intercell Austria AG

Health Services

Distribution Services

Valneva USA, Inc.

Finance

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Franck Grimaud